Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project

Author:

Audeh BissanORCID,Bellet Florelle,Beyens Marie-Noëlle,Lillo-Le Louët Agnès,Bousquet Cédric

Funder

Agence Nationale de Sécurité du Médicament et des Produits de Santé

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference82 articles.

1. Medawar C, Herxheimer A, Bell A, Jofre S. Paroxetine, Panorama and user reporting of ADRs: consumer intelligence matters in clinical practice and post-marketing drug surveillance. Int J Risk Saf Med. 2002;15(4/3):161–9.

2. Curino CA, Jia Y, Lambert B, West PM, Yu C. Mining officially unrecognized side effects of drugs by combining web search and machine learning. In: Proceedings of the 14th ACM international conference on Information and knowledge management. 2005. p. 365–72.

3. Schröder S, Zöllner YF, Schaefer M. Drug related problems with Antiparkinsonian agents: consumer internet reports versus published data. Pharmacoepidemiol Drug Saf. 2007;16(10):1161–6.

4. Scanfeld D, Scanfeld V, Larson EL. Dissemination of health information through social networks: Twitter and antibiotics. Am J Infect Control. 2010;38(3):182–8.

5. Leaman R, Wojtulewicz L, Sullivan R, Skariah A, Yang J, Gonzalez G. Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. In: Proceedings of the 2010 workshop on biomedical natural language processing. Association for Computational Linguistics, 2010. p. 117–25.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3